Xtant Medical Holdings, Inc. is a medical technology company, which is focused on the designing, development and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. The Company’s products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar and interbody spine. It promotes and sells its products in the United States through independent distributors and stocking agents. The Company also maintains a national accounts program to enable its agents to gain access to independent health delivery network hospitals and through group purchasing organizations (GPOs). Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts.